U Hess

412 total citations
8 papers, 291 citations indexed

About

U Hess is a scholar working on Hematology, Immunology and Emergency Medicine. According to data from OpenAlex, U Hess has authored 8 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Immunology and 4 papers in Emergency Medicine. Recurrent topics in U Hess's work include Acute Myeloid Leukemia Research (6 papers), Hematological disorders and diagnostics (4 papers) and Hematopoietic Stem Cell Transplantation (2 papers). U Hess is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hematological disorders and diagnostics (4 papers) and Hematopoietic Stem Cell Transplantation (2 papers). U Hess collaborates with scholars based in Germany, Switzerland and Netherlands. U Hess's co-authors include Oliver G. Ottmann, G. Seipelt, Arnold Ganser, G. Schulz, Jürgen Frisch, Alexander Maurer, Aloïs Gratwohl, Edo Vellenga, W L van Putten and A. Lindemann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

U Hess

8 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U Hess Germany 7 235 106 78 53 47 8 291
JE Landegent Netherlands 8 237 1.0× 68 0.6× 115 1.5× 145 2.7× 71 1.5× 12 407
Michael J. Keating United States 9 292 1.2× 96 0.9× 120 1.5× 49 0.9× 21 0.4× 10 400
Paola Maria Cavigliano Italy 12 324 1.4× 44 0.4× 94 1.2× 48 0.9× 63 1.3× 27 384
Michael Heinsch Germany 8 267 1.1× 48 0.5× 88 1.1× 28 0.5× 26 0.6× 14 324
G.W. Dewald United States 9 329 1.4× 51 0.5× 147 1.9× 38 0.7× 61 1.3× 11 416
T.A. Lane United States 4 231 1.0× 103 1.0× 38 0.5× 87 1.6× 47 1.0× 6 301
N Morita Japan 7 288 1.2× 72 0.7× 119 1.5× 61 1.2× 18 0.4× 9 362
RB Geller United States 9 301 1.3× 83 0.8× 58 0.7× 101 1.9× 18 0.4× 11 358
S. Alvi United States 3 368 1.6× 43 0.4× 193 2.5× 86 1.6× 47 1.0× 4 446
E. T. van’t Veer-Korthof Netherlands 4 319 1.4× 58 0.5× 122 1.6× 63 1.2× 29 0.6× 5 392

Countries citing papers authored by U Hess

Since Specialization
Citations

This map shows the geographic impact of U Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Hess more than expected).

Fields of papers citing papers by U Hess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Hess. The network helps show where U Hess may publish in the future.

Co-authorship network of co-authors of U Hess

This figure shows the co-authorship network connecting the top 25 collaborators of U Hess. A scholar is included among the top collaborators of U Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U Hess. U Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Meyer‐Monard, Sandrine, V. Parlier, Jakob Passweg, et al.. (2006). Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia. Leukemia. 20(2). 247–253. 12 indexed citations
3.
Löwenberg, Bob, M. Boogaerts, Simon Daenen, et al.. (1997). Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.. Journal of Clinical Oncology. 15(12). 3496–3506. 104 indexed citations
4.
Ganser, Arnold, G. Seipelt, Walter Verbeek, et al.. (1994). Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.. PubMed. 8(3). 369–75. 33 indexed citations
5.
Ganser, Arnold, Oliver G. Ottmann, G. Seipelt, et al.. (1993). Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes.. PubMed. 7(5). 696–701. 35 indexed citations
6.
Hess, U, A. Ganser, Schnürch Hg, et al.. (1992). MYELOKATHEXIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (rhGM‐CSF). British Journal of Haematology. 80(2). 254–256. 25 indexed citations
8.
Ganser, Arnold, G. Seipelt, M Eder, et al.. (1992). Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.. PubMed. 19(2 Suppl 4). 95–101. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026